Italian contract research organisation IRBM has signed a new agreement with Merck & Co Inc (MSD outside the USA and Canada) to continue their collaboration in the peptide therapeutics area. “The success of this collaboration is reflected by the outstanding achievements in the delivery of orally available peptide candidates,” said Elisabetta Bianchi, Senior Director of […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!